Search SCNX
Scienture Holdings, Inc.
Nasdaq · CIK 1382574
Last close0.16
Daily change-0.02 (-10.17%)
10 Years gain-80.84%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
SCNX · STANDARD
SIC 2834 · Pharmaceutical Preparations · Fiscal year end 1231
Fundamental
40.3Momentum
100.0Acceleration
80.1Confidence
77.0Annual Revenue13
Quarterly Revenue41
Annual CFO13
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth7.7 / 25
Quality10.9 / 25
Capital Efficiency4.7 / 20
Balance Sheet15.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 88.4602 percentage points.
Operating leverageOperating margin improved by 329.9185 percentage points.
ROIC expansionROIC improved by 0.0332 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Warnings
Receivables anomaly · MEDIUMAccounts receivable growth is materially above revenue growth.
Heavy share dilution · HIGHDiluted share count increased 320.2935%.
Key Metrics
Revenue Growth TTM103.66%OK
Revenue CAGR 3Y-65.21%OK
Gross Margin97.4%OK
Operating Margin-1,588.7%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-17.73%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y320.29%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $431,609.00 | $331,482.00 | -$42.59M | -$13.38M | n/a | 76.8% | -9,867.92% | n/a | -46.27% | 15.35M |
| 2025 FY Dec 31, 2024 | $136,643.00 | $6,005.00 | -$14.70M | -$14.27M | -$14.28M | 4.39% | -10,758.7% | -10,448.57% | -28.2% | 3.65M |
| 2024 FY Dec 31, 2023 | $1.36M | $49,030.00 | -$4.40M | -$2.23M | n/a | 3.6% | -322.36% | n/a | -11,836.34% | 2.38M |
| 2023 FY Dec 31, 2022 | $10.25M | $5.52M | -$2.92M | n/a | n/a | 53.85% | -28.45% | n/a | -1,458.74% | 566,609 |
| 2022 FY Dec 31, 2021 | $9.89M | $4.75M | -$5.29M | -$2.57M | -$2.59M | 47.99% | -53.51% | -26.18% | -245.42% | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $990,014.00 | sum latest 4 fiscal quarters Revenue | OK | 0001493152-26-037754, 0001493152-26-023862 |
| Revenue Growth TTM | 103.66% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001493152-26-037754, 0001493152-26-023862 |
| Revenue CAGR 3Y | -65.21% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001493152-26-013475 |
| Revenue CAGR 5Y | -52.1% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001493152-26-013475 |
| Gross Profit CAGR 3Y | -60.84% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001493152-26-013475 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001493152-26-037754, 0001493152-25-022032 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 97.4% | Gross Profit / Revenue | OK | 0001493152-26-037754, 0001493152-26-023862 |
| Operating Margin | -1,588.7% | Operating Income / Revenue | OK | 0001493152-26-037754, 0001493152-26-023862 |
| ROIC | -17.73% | NOPAT / Average Invested Capital | OK | 0001493152-26-037754, 0001493152-25-022032 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001493152-26-037754 |
| Current Ratio | 3.04x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $0.03 | Revenue / Diluted Shares | OK | 0001493152-26-037754, 0001493152-26-023862 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |